Results 101 to 110 of about 196,668 (216)

Effectiveness of bovine immunoglobulin g against salmonella infections in mice [PDF]

open access: yesEurasian Journal of Veterinary Sciences
Aim: This study was aimed to determination of effectiveness of the bovine Immuneglobuline G (IgG) against Salmonella infections caused by Salmonella Dublin, S. Typhimurium, S. Kentucky or S. Anatum.
Hasan Hüseyin Hadimli   +2 more
doaj  

Passive Antifibrinolytic Immunity.

open access: yesExperimental Biology and Medicine, 1935
As a preliminary to a study of passive antifibrinolytic immunity in laboratory animals, 5% high-titer commercial antistreptococcus serum† was added to freshly-drawn rabbit and rhesus bloods. The resulting passively immunized bloods were allowed to coagulate and serums separate. It was found that within the limits of the experimental error, the specific
openaire   +1 more source

Passive Immunization

open access: yes, 2018
Slifka, Mark K., Amanna, Ian J.
  +4 more sources

Failure of Passive Immunity Transfer Is Not a Risk Factor for Omphalitis in Beef Calves. [PDF]

open access: yesVet Sci, 2023
Perrot F   +8 more
europepmc   +1 more source

Origin of lymph node-derived lymphocytes in human hepatic allografts [PDF]

open access: yes, 1989
Hepatic allograft-derived lymph nodes were examined in the post-transplant period on order to determine the origin of lymphocytes and structural elements of the lymph node.
Chen, K   +7 more
core   +1 more source

A novel nanoparticle vaccine, based on S1-CTD, elicits robust protective immune responses against porcine deltacoronavirus

open access: yesJournal of Virology
Porcine deltacoronavirus (PDCoV), an emerging swine pathogen causing severe enteric disease in piglets, poses cross-species transmission risks, including humans.
Qing He   +16 more
doaj   +1 more source

Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen. [PDF]

open access: yes, 1990
Breaking the state of immunological unresponsiveness of tumor-bearing individuals to cancer is a prerequisite for active or passive tumor-specific immunotherapy.
Koeppen, H   +5 more
core  

Home - About - Disclaimer - Privacy